5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)Acute Ischemic Stroke, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral infarction, cerebrovascular disorder, ischemic disease, ischemic stroke, nervous system disorder, stroke disorder, vascular disorderRecruitingPhase 32026-09-24NCT06548971
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast CancerHR-positive, HER2-negative Breast NeoplasmsActive, not recruitingPhase 32026-01-07NCT05365178
Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal PolypsChronic Rhinosinusitis With Nasal Polyps (CRSwNP)RecruitingPhase 32025-12-16NCT07107256
Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed ShockVasodilatory ShockRecruitingPhase 32025-01-23NCT06351150
Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS Systemcardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorderNot yet recruitingNot applicable2021-08-06NCT04995159